UnitedHealth’s Post-CEO Death Earnings: Record Revenue, Plummeting Profits, and Executive Defenses
UnitedHealth Group reported mixed earnings results following the recent murder of executive Brian Thompson, an event that sparked public criticism of the company’s healthcare practices. CEO Andrew Witty defended the company’s role in lowering costs, attributing high prices to pharmaceutical companies and healthcare providers, while acknowledging the need for a less complex and costly US healthcare system. Witty highlighted ongoing efforts to improve the healthcare approval process and reaffirmed the company’s commitment to fully passing on drug price negotiation savings to customers. The company aims to address public concerns regarding healthcare access and affordability.
John Q. Hosedrinker